DXY’s article was part of a wave of reports that caused shares in Lianhua Qingwen’s producer — one of China’s largest traditional medicine companies — to plunge. A popular Chinese medical information site has been censored by authorities for “violation of relevant laws and regulations”, months after its criticism of a government-backed herbal COVID-19 treatment...
